Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

GeneDx Holdings (WGS) Leases (2020 - 2026)

GeneDx Holdings has reported Leases over the past 7 years, most recently at $34.7 million for Q1 2026.

  • Quarterly Leases rose 39.26% to $34.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $34.7 million through Mar 2026, up 39.26% year-over-year, with the annual reading at $23.4 million for FY2025, 8.59% down from the prior year.
  • Leases was $34.7 million for Q1 2026 at GeneDx Holdings, up from $23.4 million in the prior quarter.
  • Over five years, Leases peaked at $44.0 million in Q2 2022 and troughed at $3.4 million in Q4 2023.
  • The 5-year median for Leases is $25.6 million (2024), against an average of $26.0 million.
  • Year-over-year, Leases tumbled 89.5% in 2023 and then soared 644.56% in 2024.
  • A 5-year view of Leases shows it stood at $32.8 million in 2022, then tumbled by 89.5% to $3.4 million in 2023, then soared by 644.56% to $25.6 million in 2024, then decreased by 8.59% to $23.4 million in 2025, then skyrocketed by 48.01% to $34.7 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Leases are $34.7 million (Q1 2026), $23.4 million (Q4 2025), and $24.2 million (Q3 2025).